Remote ischemic conditioning may improve outcomes of patients with cerebral small-vessel disease

Stroke

Volumn 48, Issue 11, 2017, Pages 3064-3072

  Wang, Yuan ^a   Meng, Ran ^a   Song, Haiqing ^a   Liu, Gang ^a   Hua, Yang ^a   Cui, Dehua ^a,b   Zheng, Lemin ^a,b   Feng, Wuwei ^c   Liebeskind, David S ^d   Fisher, Marc ^e   Ji, Xunming ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cerebral small vessel diseases; Cognition; Risk factors; Stroke

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN SIZE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXECUTIVE FUNCTION; FOLLOW UP; HEMODYNAMICS; HUMAN; ISCHEMIC PRECONDITIONING; MIDDLE CEREBRAL ARTERY; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSATILITY INDEX; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UPPER LIMB; WHITE MATTER; BRAIN CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITIVE DYSFUNCTION; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITIVE DYSFUNCTION; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 85032169734     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.117.017691     Document Type: Article

References (43)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701. doi: 10.1016/S1474-4422 (10) 70104-6.
2. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838. doi: 10.1016/S1474-4422 (13) 70124-8.
3. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197-2204. doi: 10.1212/01. wnl.0000271090.28148.24.
4. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497. doi: 10.1016/S1474-4422 (13) 70060-7.
5. Benjamin P, Viessmann O, MacKinnon AD, Jezzard P, Markus HS. 7 Tesla MRI in cerebral small vessel disease. Int J Stroke. 2015;10:659-664. doi: 10.1111/ijs.12490.
6. Meng R, Asmaro K, Meng L, Liu Y, Ma C, Xi C, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012;79:1853-1861. doi: 10.1212/WNL.0b013e318271f76a.
7. Meng R, Ding Y, Asmaro K, Brogan D, Meng L, Sui M, et al. Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment. Neurotherapeutics. 2015;12:667-677. doi: 10.1007/s13311-015-0358-6.
8. Mi T, Yu F, Ji X, Sun Y, Qu D. The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. Eur Neurol. 2016;76:28-34. doi: 10.1159/000447536.
9. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246. doi: 10.1111/j.1365-2796.2004.01380.x.
10. Jia J, Wei C, Liang J, Zhou A, Zuo X, Song H, et al. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial. Alzheimers Dement. 2016;12:89-99. doi: 10.1016/j.jalz.2015.04.010.
11. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007;52:329-332. doi: 10.1177/070674370705200508.
12. Zhao L, Barlinn K, Sharma VK, Tsivgoulis G, Cava LF, Vasdekis SN, et al. Velocity criteria for intracranial stenosis revisited: an international multicenter study of transcranial Doppler and digital subtraction angiography. Stroke. 2011;42:3429-3434. doi: 10.1161/STROKEAHA.111.621235.
13. Deweese JA, May AG, Lipchik EO, Rob CG. Anatomic and hemodynamic correlations in carotid artery stenosis. Stroke. 1970;1:149-157.
14. Yu J, Li J, Huang X. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry. 2012;12:156. doi: 10.1186/1471-244X-12-156.
15. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
16. Kidwell CS, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. Transcranial Doppler pulsatility indices as a measure of diffuse smallvessel disease. J Neuroimaging. 2001;11:229-235.
17. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006;66:23-29. doi: 10.1212/01.wnl.0000191403.95453.6a.
18. Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke. 2011;42:1387-1391. doi: 10.1161/STROKEAHA.110.605840.
19. Schmidt R, Seiler S, Loitfelder M. Longitudinal change of small-vessel disease-related brain abnormalities. J Cereb Blood Flow Metab. 2016;36:26-39. doi: 10.1038/jcbfm.2015.72.
20. Wallin A, Ohrfelt A, Bjerke M. Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease. J Neurol Sci. 2012;322:192-196. doi: 10.1016/j.jns.2012.07.068.
21. Thushara Vijayakumar N, Sangwan A, Sharma B, Majid A, Rajanikant GK. Cerebral Ischemic Preconditioning: the Road So Far⋯. Mol Neurobiol. 2016;53:2579-2593. doi: 10.1007/s12035-015-9278-z.
22. Gidday JM. Cerebrovascular ischemic protection by pre- and post-conditioning. Brain Circ. 2015;1:97-103.
23. Chen Y, Wang A, Tang J, Wei D, Li P, Chen K, et al. Association of white matter integrity and cognitive functions in patients with subcortical silent lacunar infarcts. Stroke. 2015;46:1123-1126. doi: 10.1161/STROKEAHA.115.008998.
24. Pavlovic AM, Pekmezovic T, Tomic G, Trajkovic JZ, Sternic N. Baseline predictors of cognitive decline in patients with cerebral small vessel disease. J Alzheimers Dis. 2014;42(suppl 3):S37-S43. doi: 10.3233/JAD-132606.
25. Baune BT, Roesler A, Knecht S, Berger K. Single and combined effects of cerebral white matter lesions and lacunar infarctions on cognitive function in an elderly population. J Gerontol A Biol Sci Med Sci. 2009;64:118-124. doi: 10.1093/gerona/gln004.
26. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36:2116-2120. doi: 10.1161/01. STR.0000179092.59909.42.
27. Wang Y, Ji X, Leak RK, Chen F, Cao G. Stem cell therapies in age-related neurodegenerative diseases and stroke. Ageing Res Rev. 2017;34:39-50. doi: 10.1016/j.arr.2016.11.002.
28. Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury in ischemic stroke. Prog Neurobiol. 2016;141:45-60. doi: 10.1016/j. pneurobio.2016.04.005.
29. Turan TN, Smock A, Cotsonis G, Bachman D, Al Kasab S, Lynn MJ, et al; SAMMPRIS Investigators. Is there benefit from stenting on cognitive function in intracranial atherosclerosis? Cerebrovasc Dis. 2017;43:31-35. doi: 10.1159/000450964.
30. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699. doi: 10.1111/j.1532-5415.2005.53221.x.
31. Hess DC, Khan MB, Morgan JC, Hoda M. Remote ischemic conditioning: a treatment for vascular cognitive impairment. Brain Circ. 2015;1:133-139.
32. Verdelho A, Madureira S, Ferro JM, Baezner H, Blahak C, Poggesi A, et al; LADIS Study. Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study. Stroke. 2012;43:3331-3335. doi: 10.1161/STROKEAHA.112.661793.
33. Frederiksen KS, Verdelho A, Madureira S, Bäzner H, O'Brien JT, Fazekas F, et al; LADIS Study. Physical activity in the elderly is associated with improved executive function and processing speed: the LADIS Study. Int J Geriatr Psychiatry. 2015;30:744-750. doi: 10.1002/gps.4220.
34. Khan MB, Hoda MN, Vaibhav K, Giri S, Wang P, Waller JL, et al. Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment. Transl Stroke Res. 2015;6:69-77. doi: 10.1007/s12975-014-0374-6.
35. Shin DW, Lee KB, Seo JY, Kim JS, Roh H, Ahn M Y, et al. Association between Hypertriglyceridemia and Lacunar Infarction in Type 2 Diabetes Mellitus. J Stroke Cerebrovasc Dis. 2015;24:1873-1878. doi: 10.1016/j. jstrokecerebrovasdis.2015.04.030.
36. Vilar-Bergua A, Riba-Llena I, Nafría C, Bustamante A, Llombart V, Delgado P, et al. Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability. J Cereb Blood Flow Metab. 2016;36:55-71. doi: 10.1038/jcbfm.2015.68.
37. Jeong SK, Kim DH, Cho YI. Homocysteine and pulsatility index in lacunar infarction. Clin Neurol Neurosurg. 2011;113:459-463. doi: 10.1016/j.clineuro.2011.01.016.
38. Agrawal A, Ilango K, Singh PK, Karmakar D, Singh GP, Kumari R, et al. Age dependent levels of plasma homocysteine and cognitive performance. Behav Brain Res. 2015;283:139-144. doi: 10.1016/j. bbr.2015.01.016.
39. Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56:215-228. doi: 10.3233/JAD-160826.
40. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke. 2011;6:47-59. doi: 10.1111/j.1747-4949.2010.00552.x.
41. Ghorbani A, Ahmadi MJ, Shemshaki H. The value of transcranial Doppler derived pulsatility index for diagnosing cerebral small-vessel disease. Adv Biomed Res. 2015;4:54. doi: 10.4103/2277-9175.151574.
42. Webb AJ, Simoni M, Mazzucco S, Kuker W, Schulz U, Rothwell PM. Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility. Stroke. 2012;43:2631-2636. doi: 10.1161/STROKEAHA.112.655837.
43. Kim Y, Lee H, An SA, Yim B, Kim J, Kim OJ, et al. The effect of pulsatility index on infarct volume in acute lacunar stroke. Yonsei Med J. 2016;57:950-955. doi: 10.3349/ymj.2016.57.4.950.